Adaptive Trial Leadership Berry Consultants excels in designing adaptive clinical trials, platform trials, and Bayesian analysis, presenting a strong opportunity to upsell their advanced trial design services to sponsors seeking efficiency, flexibility, and accelerated timelines.

Software Solutions Upsell With proprietary tools like QUOTES, ADDPLAN, and FACTS, there is a clear path to expand into licensed software modules for existing clients and cross-sell to new sponsors needing robust simulation and planning capabilities.

Strategic Partnerships Their collaboration history with FDA, EMA, NIH, PCORI, and international funders signals potential for multi-stakeholder engagements, enabling joint development programs, real-world evidence studies, and large-scale procurements.

Growth Through Alliances The strong revenue range and focused niche in research services indicate potential for targeted outreach to mid-to-large biopharma and medical device companies seeking expert trial design and operational excellence to de-risk complex programs.

Global Exposure Berry’s international project footprint and recent news on partnerships suggest opportunities to pursue global trials, compliance-enabled services, and localization of design strategies for multinational sponsor pipelines.